US Market Report for Therapeutic Obstructive Sleep Apnea Devices 2017 – MedCore

US Market Report for Therapeutic Obstructive Sleep Apnea Devices 2017 – MedCore

0

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 243
  • Type: MedCore

Obstructive sleep apnea is a respiratory disorder wherein an individual’s airway is obstructed during sleep as muscles relax and the airway walls and tissue collapse. The resulting asphyxia arouses the individual from the deeper stages of sleep so that normal breathing can be restored. It is this disruption of regular sleep rhythms that causes the negative symptoms associated with sleep apnea. During these events (termed “apneic events”), breathing ceases long enough to allow several normal breaths to be missed. In order to be considered an apneic event, a ten second interval between breaths and neurological arousal and/or blood oxygen desaturation are required. In most cases, the sufferer is unaware of experiencing such an event at the time, often simply falling back asleep afterwards.

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
The market for sleep apnea therapy products has been growing over the years as diagnosis is becoming more prevalent. Patients are becoming more aware of this condition as apparent by the increasing number of PAP initiation and management procedures being conducted at hospitals.
This market has consistently been known to be limited by inefficiencies and patient discomfort for the devices required. Consequently, technology has been ever evolving and market segment growth continues to shift from one technology form to another. Similar to the oxygen therapy market, the market for sleep apnea devices is restricted by the Competitive Bidding Program, with consistent ASP declines as manufacturers push lower priced item products to win contracts for the Medicare program.
Over 50% of sleep apnea patients are covered by Medicare. With the aging population, this segment is set to drive growth of this market overall. Included in the sleep apnea market are the various positive airway pressure (PAP) devices as well as the market for the corresponding PAP masks which are used alongside the device. The market for PAP devices includes continuous positive airway pressure (CPAP) devices, auto-titrating positive airway pressure (APAP) devices, and bi-level positive airway pressure (BiPAP) devices. These devices are categorized collectively as sleep therapy interfaces and correspond to the following PAP device masks: nasal pillow masks, full face masks and nasal masks. The market for sleep therapy devices is nearly double in size of the PAP device market as these consumables require replacement multiple times per year.
In general, almost all patients diagnosed with sleep apnea are covered by some sort of insurance policy. Most of sleep therapy products, i.e. devices and related masks are included in these plans
Overall, the market for sleep therapy interfaces (masks) is set to grow at a faster rate than the positive airway market at a CAGR of 10.4%. Specifically driving growth in that market is the full-face and nasal pillow options are they offer greater patient comfort and have grown quite drastically in recent years. On the other hand, within the PAP device market, there has been a significant shift in markets away from CPAP devices towards APAP versions.



The "US Market Report Suite for Anesthesia, Respiratory and Sleep Management Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Philips Respironics
ResMed
CAIRE Inc.
Becton Dickinson
GE Healthcare
Covidien
DeVilbiss
Invacare
Dr?ger
Teleflex
Fisher & Paykel
Inogen
Smiths Medical
Ambu
Mindray
Omron
Maquet
Westmed
Natus Medical
Others include: Airgas, BD-CareFusion, Cramer Decker, eVent, Flexicare, Flotec, Fukuda Denshi, GE Healthcare, Global Medical Holdings, Graham Field, Intersurgical, Invacare, Mada Medical, Maquet, Massimo, Medis, Mercury Medical, Metal Impact, Nellcor, Nidek, O2 Concepts, Oxlife, Penlon, Percussionaire, Philips Respironics, Sechrist, Somnostar, Spacelabs, SunMed, Teleflex, Ventlab, VisionAire, Welch Allyn, Zoll, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×